Enliven Therapeutics, Inc. (ELVN) Earnings
|
Expand Research on ELVN
| Next EPS Date | 8/19/26 | EPS Growth Rate | +22.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +7.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/26  |
Q126 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/20/26 |
Q126 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/3/26 |
Q425 | -$0.48 | -$0.46 | -$0.02 | N/A | $8.33K | N/A |  | | Details | |
| 11/12/25 | Q325 | -$0.32 | -$0.50 | +$0.18 | N/A | N/A | N/A | | | Details | |
| 11/11/25 |
Q325 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A |
